LNWWM
ABBV icon

Laird Norton Wetherby Wealth Management’s AbbVie ABBV Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$5K – 465
2015
Q3 		$5K Buy
+100
New +$6.51K ﹤0.01% 455

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's ABBV Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management increased its AbbVie (ABBV) stake by 0.45% in Q3 2025, buying an estimated $40.5K and bringing the position to 44,878 shares worth $10.4M. The position accounts for 0.42% of the portfolio, ranked #30.

Laird Norton Wetherby Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. 3,915 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 44,878 shares of AbbVie worth $10.4M as of Q3 2025.
  • Laird Norton Wetherby Wealth Management bought 199 AbbVie shares in Q3 2025, an estimated $40.5K.
  • AbbVie made up 0.42% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #30 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
  • 3,915 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.